Cancer Chemotherapy and Pharmacology

, Volume 33, Supplement 1, pp S103–S108 | Cite as

Outcomes of 116 patients with hepatocellular carcinoma

  • Hiroyoshi Onodera
  • Katsuaki Ukai
  • Noboru Nakano
  • Tetsutaro Takeda
  • Hiroshi Suzuki
  • Toshiki Okata
  • Tadashi Motojima
  • Ichiro Kuwashima
  • Shigenori Ujiie
  • Tadami Shoji
Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-2 Hepatocellular Carcinoma, Interventional Radiology

Abstract

We studied the outcomes of 116 patients with hepatocellular carcinoma (HCC) diagnosed in our hospital between January 1980 and August 1992. The patients were divided into groups according to the principal treatment procedure. The 3-year survival rates in the patients treated by percutaneous ultrasonically guided ethanol injection (PEI), operation (hepatic resection), and transcatheter hepatic arterial embolization (TAE) were 90.9%, 53.6%, and 29.0%, respectively. None of the patients treated by oneshot injection of an anticancer agent into the hepatic artery and chemotherapy survived for more than 2 years. The outcomes of the patients treated by PEI and hepatic resection were significantly better than those of the patients treated by the other procedures. There was no significant difference when the patients were stratified according to the year of detection. The 3-year survival rate was 57.3% for 19 patients in whom HCCs were detected during clinical follow-up for chronic liver disease and 17.3% for the other 97 patients. We concluded that hepatic resection in patients with good liver function and PEI for early HCC yielded significantly better survival rates than the other procedures. Moreover, for early detection and treatment of HCC, we recommend clinical follow-up of patients with chronic liver disease.

References

  1. 1.
    Akagi G, Furuya K, Otsuka H (1982) Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku, Japan. Cancer 49: 678Google Scholar
  2. 2.
    Chuang VC, Wallace S (1981) Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 140: 51Google Scholar
  3. 3.
    Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, Morita M, Saisho H, Tsuchiya Y, Okuda K (1986) Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. Gastroenterology 90: 289Google Scholar
  4. 4.
    Fujimoto T, Majima Y, Tanaka M (1986) Investigation of percutaneous ultrasonographically guided ethanol injection therapy (PEIT) for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 27: 1559Google Scholar
  5. 5.
    Goldstein HM, Wallace S, Anderson JH, Bree RL, Giantureo C (1976) Transcatheter occlusion of abdominal tumors. Radiology 120: 539Google Scholar
  6. 6.
    Kiyosawa K, Sodeyama T, Tanaka E (1990) Interrelationship of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma, analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671Google Scholar
  7. 7.
    Kubo Y, Okuda K, Musha H, Nakashima T (1978) Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver diseases. Gastroenterology 74: 578Google Scholar
  8. 8.
    Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, Pao CC (1986) Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. Gastroenterology 90: 263Google Scholar
  9. 9.
    Liver Cancer Study Group of Japan (1984) Primary liver cancer in Japan. Cancer 54: 1747Google Scholar
  10. 10.
    Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Ann Surg 211: 277Google Scholar
  11. 11.
    Liver Cancer Study Group of Japan (1992) The general rules for the clinical and pathological study of primary liver cancer. Kanehara & Co., TokyoGoogle Scholar
  12. 12.
    Livraghi T, Festi D, Monti F, Salmi A, Vettori C (1986) US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 161: 309Google Scholar
  13. 13.
    Obata H, Hayashi N, Motoike Y (1980) A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer 25: 741Google Scholar
  14. 14.
    Ohishi H, Uchida H, Yoshimura H, Ohue S, Ueda J, Katsuragi M, Matsuo N, Hosogi Y (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154: 25Google Scholar
  15. 15.
    Onodera H, Oikawa M, Abe M, Chida N, Kimura S, Goto Y (1986) Intraarterial injection of large amount of iodized oil (Lipiodol) for the treatment of unresectable hepatoma. Jpn J Clin Radiol 31: 269Google Scholar
  16. 16.
    Onodera H, Chida N, Kimura S, Goto Y, Sugawara N (1988) Malignant neoplasms detected in the mass survey for hepatic, biliary tract and pancreatic diseases. Jpn J Med Ultrasonics 15: 45Google Scholar
  17. 17.
    Onodera H, Kanazawa Y, Takeda T, Sugawara N, Fukao A, Chida N (1989) Ultrasonic mass survey for hepatic, biliary tract and pancreatic diseases. Jpn J Gastroenterol Mass Survey 85: 40Google Scholar
  18. 18.
    Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kuo G (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6547Google Scholar
  19. 19.
    Sheu JC, Sung JL, Chen DS, Lai MY, Wang TH, Yu JY, Yang PM, Chuang CN, Yang PC, Lee CS, Hsu HC, How SW (1985) Early detection of hepatocellular carcinoma by real-time ultrasonography. Cancer 56: 660Google Scholar
  20. 20.
    Shiina S, Yasuda H, Muto H, Tazawa K, Unuma T, Ibukuro K, Inoue Y, Takanashi R (1987) Percutaneous ethanol injection in the treatment of liver neoplasms. AJR 149: 949Google Scholar
  21. 21.
    Shinagawa T, Ukaji H, Iino Y (1985) Intratumoral injection of absolute ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 26: 99Google Scholar
  22. 22.
    Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H, Hirohashi S (1987) Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 162: 345Google Scholar
  23. 23.
    Takeda S, Shibata M, Morishima T, Harada A, Nakao A, Takagi H, Nagai Y (1992) Hepatitis C virus infection in hepatocellular carcinoma. Cancer 70: 2255Google Scholar
  24. 24.
    Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148: 397Google Scholar
  25. 25.
    Yano M, Yatsuhashi H, Inoue O, Koga M (1991) Epidemiology of hepatitis C virus in Japan: role in chronic liver disease and hepatocellular carcinoma. J Gastroenterol Hepatol [Suppl 1] I: 31Google Scholar
  26. 26.
    Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K, Okada K (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154: 19Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • Hiroyoshi Onodera
    • 1
  • Katsuaki Ukai
    • 1
  • Noboru Nakano
    • 1
  • Tetsutaro Takeda
    • 1
  • Hiroshi Suzuki
    • 1
  • Toshiki Okata
    • 1
  • Tadashi Motojima
    • 1
  • Ichiro Kuwashima
    • 1
  • Shigenori Ujiie
    • 1
  • Tadami Shoji
    • 1
  1. 1.Department of Internal MedicineMiyagi Cancer Center HospitalNatori, Miyagi PrefectureJapan

Personalised recommendations